photopheresis for treatment of chronic graft-versus-host disease A multicenter prospective phase 2 randomized study of extracorporeal

doi:10.1182/blood-2008-03-141481Prepublished online July 11, 2008;2008 112: 2667-2674€€€€Robert Knobler, Dennis Parenti, Jose Gallo and Hildegard T. GreinixReddy, Andrea Bacigalupo, Hans-Jochem Kolb, Luis Bouzas, Mauricette Michallet, H. Miles Prince, Mary E. D. Flowers, Jane F. Apperley, Koen van Besien, Ahmet Elmaagacli, Andrew Grigg, Vijay€

[1]  Hyon K. Choi,et al.  The risk of hospitalized infection in patients with rheumatoid arthritis. , 2008, The Journal of rheumatology.

[2]  H. Greinix,et al.  A single-center pilot validation study of a new chronic GVHD skin scoring system. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  M. Turner,et al.  Cutaneous manifestations of chronic graft-versus-host disease. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  G. Socié,et al.  Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials , 2006, Bone Marrow Transplantation.

[5]  P. Taylor,et al.  Extracorporeal photopheresis: a focus on apoptosis and cytokines. , 2006, Journal of dermatological science.

[6]  M. Albert,et al.  Assessing the potential role of photopheresis in hematopoietic stem cell transplant , 2006, Bone Marrow Transplantation.

[7]  J. Ritz,et al.  Rituximab for steroid-refractory chronic graft-versus-host disease. , 2006, Blood.

[8]  E. Shpall,et al.  Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. , 2006, Blood.

[9]  P. Taylor,et al.  The down‐regulation of IL1α and IL6, in monocytes exposed to extracorporeal photopheresis (ECP)‐treated lymphocytes, is not dependent on lymphocyte phosphatidylserine externalization , 2006, Transplant international : official journal of the European Society for Organ Transplantation.

[10]  Steven Hirschfeld,et al.  Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report , 2006 .

[11]  D. Peritt.  Potential mechanisms of photopheresis in hematopoietic stem cell transplantation. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[12]  P. Rubegni,et al.  Role of extracorporeal photochemotherapy in patients with refractory chronic graft‐versus‐host disease , 2005, British journal of haematology.

[13]  F. Foss,et al.  Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors , 2005, Bone Marrow Transplantation.

[14]  Stephanie J. Lee.  New approaches for preventing and treating chronic graft-versus-host disease. , 2005, Blood.

[15]  A. Nademanee,et al.  Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[16]  R. Storb,et al.  Duration of immunosuppressive treatment for chronic graft-versus-host disease. , 2004, Blood.

[17]  M. Flowers,et al.  Chronic graft-versus-host disease. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[18]  J. Apperley,et al.  Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response. , 2003, Blood.

[19]  G. Dini,et al.  Extracorporeal photochemotherapy for paediatric patients with graft‐versus‐host disease after haematopoietic stem cell transplantation , 2003, British journal of haematology.

[20]  D. Couriel,et al.  Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results , 2003, Bone Marrow Transplantation.

[21]  E. Cook,et al.  Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[22]  R. Storb,et al.  Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. , 2002, Blood.

[23]  A. Pession,et al.  Extracorporeal photochemotherapy for treatmentof acute and chronic GVHD in childhood , 2001, Transfusion.

[24]  H. Greinix,et al.  Extracorporeal Photochemotherapy in the Treatment of Severe Graft-Versus-Host Disease , 2000, Leukemia & lymphoma.

[25]  G. Vogelsang,et al.  Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus , 1999, Bone Marrow Transplantation.

[26]  H. Hönigsmann,et al.  Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. , 1998, Blood.

[27]  A. Nademanee,et al.  Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host disease. , 1998, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[28]  F. Locatelli,et al.  Photopheresis in paediatric patients with drug‐resistant chronic graft‐versus‐host disease , 1997, British journal of haematology.

[29]  W. Siegert,et al.  Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. , 1994, Bone marrow transplantation.